Dr. Lal Path Labs Ltd. (LALPATHLAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.134x

Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) has a cash flow conversion efficiency ratio of 0.134x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.24 Billion ≈ $35.04 Million USD) by net assets (Rs24.22 Billion ≈ $261.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Dr. Lal Path Labs Ltd.'s balance sheet to measure how much of total assets are equity-financed.

Dr. Lal Path Labs Ltd. - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Dr. Lal Path Labs Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LALPATHLAB operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Dr. Lal Path Labs Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dr. Lal Path Labs Ltd. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kinaxis Inc TO:KXS	0.148x
Stella-Jones Inc. TO:SJ	0.022x
Koninklijke Heijmans N.V. AS:HEIJM	0.383x
Elmos Semiconductor SE F:ELG	0.017x
CITIC Heavy Industries Co Ltd SHG:601608	0.033x
CITY DEV.LTD.ADR/1 SD-50 F:CDE0	N/A
IAC Inc. NASDAQ:IAC	0.003x
Bank of Chongqing Co Ltd SHG:601963	-0.066x

Annual Cash Flow Conversion Efficiency for Dr. Lal Path Labs Ltd. (2011–2026)

The table below shows the annual cash flow conversion efficiency of Dr. Lal Path Labs Ltd. from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see Dr. Lal Path Labs Ltd. (LALPATHLAB) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs25.41 Billion ≈ $274.83 Million	Rs7.02 Billion ≈ $75.92 Million	0.276x	+7.16%
2025-03-31	Rs22.07 Billion ≈ $238.62 Million	Rs5.69 Billion ≈ $61.51 Million	0.258x	-9.21%
2024-03-31	Rs18.85 Billion ≈ $203.89 Million	Rs5.35 Billion ≈ $57.89 Million	0.284x	+5.82%
2023-03-31	Rs17.00 Billion ≈ $183.79 Million	Rs4.56 Billion ≈ $49.31 Million	0.268x	-7.28%
2022-03-31	Rs15.44 Billion ≈ $166.93 Million	Rs4.47 Billion ≈ $48.31 Million	0.289x	-7.25%
2021-03-31	Rs12.76 Billion ≈ $138.00 Million	Rs3.98 Billion ≈ $43.06 Million	0.312x	+15.85%
2020-03-31	Rs10.54 Billion ≈ $113.99 Million	Rs2.84 Billion ≈ $30.70 Million	0.269x	+17.20%
2019-03-31	Rs9.51 Billion ≈ $102.84 Million	Rs2.19 Billion ≈ $23.63 Million	0.230x	-7.30%
2018-03-31	Rs7.95 Billion ≈ $85.97 Million	Rs1.97 Billion ≈ $21.31 Million	0.248x	-4.36%
2017-03-31	Rs6.62 Billion ≈ $71.61 Million	Rs1.72 Billion ≈ $18.56 Million	0.259x	-10.07%
2016-03-31	Rs5.10 Billion ≈ $55.10 Million	Rs1.47 Billion ≈ $15.88 Million	0.288x	+1.14%
2015-03-31	Rs3.43 Billion ≈ $37.14 Million	Rs978.50 Million ≈ $10.58 Million	0.285x	-32.12%
2014-03-31	Rs2.33 Billion ≈ $25.23 Million	Rs979.58 Million ≈ $10.59 Million	0.420x	-22.03%
2013-03-31	Rs1.64 Billion ≈ $17.70 Million	Rs881.31 Million ≈ $9.53 Million	0.538x	-7.47%
2012-03-31	Rs1.17 Billion ≈ $12.66 Million	Rs681.28 Million ≈ $7.37 Million	0.582x	+30.20%
2011-03-31	Rs934.94 Million ≈ $10.11 Million	Rs417.87 Million ≈ $4.52 Million	0.447x	--

About Dr. Lal Path Labs Ltd.

NSE:LALPATHLAB India Diagnostics & Research

Market Cap

$3.06 Billion

Rs282.74 Billion INR

Market Cap Rank

#4765 Global

#218 in India

Share Price

Rs1693.30

Change (1 day)

+0.35%

52-Week Range

Rs1307.60 - Rs3473.50

All Time High

Rs4119.53